Outros livros que poderiam interessá-lo

• 

  Running with Purpose - How...

  Jim Weber

  • 0
  • 0
  • 0

  Read by the author. 
  Discover how Brooks Running Company CEO Jim Weber transformed a failing business into a billion-dollar brand in the ultracompetitive global running market. 
  Running with Purpose is a leadership memoir with insights, inspirational stories, and tangible takeaways for current and aspiring leaders, entrepreneurs, and the 150+ million runners worldwide and those in the broader running community who continually invest in themselves. 
  This leadership memoir starts with Jim Weber's seventh-grade dream to run a successful company that delivered something people passionately valued. Fast forward to 2001, Jim became the CEO of Brooks and, as the struggling brand's fourth CEO in two years, he faced strong headwinds. A lifelong competitor, Jim devised a one-page strategy that he believed would not only save the company but would also lay the foundation for Brooks to become a leading brand in the athletic, fitness, and outdoor categories. To succeed, he had to get his team to first believe it was possible and then employ the conviction, fortitude, and constancy of purpose to outperform larger brands. Brooks’s success was validated when Warren Buffett made it a standalone Berkshire Hathaway subsidiary in 2012. In Running with Purpose, you will find:Brooks’s bold strategy and unique brand positioning that fueled its move from the back of the pack to lead.The key to building a purpose-driven brand that is oriented around customer obsession, building trust, competing with heart, and having fun along the way.The six clear leadership lessons Jim has learned along his path and applies at Brooks to develop staff into authentic leaders.How Berkshire Hathaway's support and influence provided a tailwind for Brooks’s business and brand to surge.An inside look at the ups and downs of Jim's personal journey, which led to his conviction that life is too short not to enjoy what you do and the people by your side. 
  Photos and graphics are included in the audiobook companion PDF download.

  Ver livro

• 

  CEO Ready - What You Need to...

  Byron Loflin, Mark Thompson,...

  • 0
  • 0
  • 0

  Your track record isn't enough. Here's what it really takes to be CEO Ready. 
   
   
   
  You're on the short list for the CEO job and you have a record of delivering amazing results. You've been told you have the inside track. You're the leader in the clubhouse. 
   
   
   
  Don't believe it. Remember that no matter what you've heard or what your CV says, you are not alone in the race, and the odds are against you getting the job. 
   
   
   
  Leadership selection isn't the methodical, objective process we imagine. Decisions aren't made by robotic executives ticking boxes for attributes like strategic fit, core competencies, or cultural alignment. Instead, the process is deeply personal, emotional, and often unpredictable. If you think it's purely merit-based, you're not CEO ready. 
   
   
   
  But don't worry, Mark Thompson and Byron Loflin have coached thousands of candidates through the process and have seen it all—they know what it takes to become truly CEO ready and they're sharing it here. They've witnessed the personal drama that unfolds as a company prepares to pass the baton of leadership, as well as the emotions that sway final CEO decisions. In CEO Ready, they reveal what it really takes to secure the top job.

  Ver livro

• 

  How to Cultivate Belief in Every...

  Victoria David

  • 0
  • 0
  • 0

  How to Cultivate Belief in Every Step: Success Without Fear is your ultimate guide to unlocking unshakable confidence and unstoppable momentum. This book teaches you how to quiet doubt, overcome fear, and embrace action with conviction. Through practical strategies, real-world examples, and empowering mindset shifts, you’ll learn to trust your instincts, take bold steps forward, and create consistent progress toward your dreams. Whether you’re striving for personal growth, professional success, or a deeper sense of purpose, this book will help you cultivate belief in every step you take, turning uncertainty into courage and hesitation into action.

  Ver livro

• 

  The Insider's Guide to...

  Dean Carignan, JoAnn Garbin,...

  • 0
  • 0
  • 0

  In this unique guide, you’re not just reading about innovation—you're learning how to do it from the people behind some of the biggest breakthroughs of the last 50 years at one of the most influential and valuable companies in the world. 
    
  Are there innovation truisms that hold from one initiative to the next? Are there strategies that appear again and again in the success stories of businesses as varied as gaming and cloud infrastructure? Are there behaviors common to creative leadership in every role, from research to sales? And if these patterns exist, could they be distilled into teachable practices? These are the questions Dean Carignan and JoAnn Garbin, two senior innovation leaders at Microsoft, set out to answer. 
    
  The Insider’s Guide to Innovation at Microsoft reveals the patterns behind Microsoft’s biggest wins and losses—from the Xbox revolution to the Windows Mobile miss and the unexpected rise of Bing in AI. Based on dozens of interviews only fellow “Microsofties” could secure, this book shares behind-the-scenes stories brimming with insights and proven practices that transcend time and technology.

  Ver livro

• 

  52 Weeks to Fearless--What...

  Peggy Doviak

  • 0
  • 0
  • 0

  With a background in music, creative writing, and education, Peggy Doviak went into finance when a stockbroker exploited her mother. Now a CERTIFIED FINANCIAL PLANNERTM professional and bestselling author, she has spent more than twenty years helping others avoid what her mother experienced. 
  Peggy’s award-winning personal finance books offer bite-sized pieces of financial information and activities to help you apply what you’ve read. In 52 Weeks to Fearless, creatives are invited to Ask Peggy® questions about their money. Finances can be intimidating when your passion is in the arts. 
  Earning money as a creative presents challenges. How do you budget when your income is uneven? How do you pay your income taxes when you don’t have a traditional employer? How can you save for retirement without a 401(k)? If your creative endeavor is a business, how do you choose the structure? How do you handle payroll taxes? Most importantly, how do you convince the IRS that your creative endeavor is not a hobby? In 52 Weeks to Fearless, Peggy answers these questions and more!

  Ver livro

• 

  The Impact of Off-Label...

  Vanessa Plate

  • 0
  • 0
  • 0

  In times of situational therapeutic impasse, health care professionals (HCPs) are under pressure to conduct off-label, unlicensed and compassionate drug use – generally summarized under the term non-licensed drug use (NDU). Liability, contractual and penal risks pose a problem when treating a patient in a non-licensed way. There is a knowledge gap about institutional and governmental methods to resolve these problems. Different countries have developed strategies to manage NDU.  In her book, Vanessa Platé compares the effects of NDU on pharmaceutical legislation in selected industrial countries and determines strategies brought forth by NDU. Furthermore, the development of a general regulatory approach to the management of NDU is sought.  Semi-structured qualitative interviews, comparison of laws, and literature research are part of this study, which includes Canada, the U.S., the U.K., Japan, France, Germany, Switzerland, Austria, and the transnational E.U. The comparison of the impact of NDU focuses on terminology for NDU, supply and necessity of NDU, pharmaceutical promotion of NDU, legal responsibility for NDU, and public policies related to NDU.  The results of the study suggest there is indeed a circumstantial need for off-label, unlicensed and compassionate use, but also showed isolated evidence suggesting intermittent non-rational NDU. Furthermore, the legal comparison showed evidence of legal obligations for physicians to perform off-label, unlicensed and compassionate drug use. Vanessa Platé also found proof of inappropriate off-label marketing on the part of market authorization holders (MAH). On the other hand, a demand for information on NDU on behalf of HCPs was present. Obtained results illustrate cross-liability for HCPs and MAH. Finally, results demonstrated regulatory strategies of different efficiencies: In the E.U., for instance, incentives for new indications were (a) limited to one year or (b) restricted to (i) pediatrics or (ii) rare disorders.  The absence of statutory terminology causes incoherent interpretation of NDU across the researched nations; harmonization is crucial for an effective concept development. There is a situational need for early access to yet unapproved treatments. Denial of (non-licensed) treatment is considered unethical. Proposed solutions for an enduring management of NDU are firstly the amendments of templates for patient information leaflets by competent authorities to include well-recognised off-label use, secondly full development, research and duly authorized marketing of medicinal products used compassionately, and thirdly, modelled on German procedure, a modified standard market authorization for essential unlicensed drugs.

  Ver livro